15.23
-0.28 (-1.81%)
-0.28 (-1.81%)
Upgrade to Real-Time
Regular Market
Low
9.01
High
21.30
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aerie Pharmaceuticals Inc | AERI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.28 | -1.81% | 15.23 | 13:34:06 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 15.58 | 15.12 | 15.70 | 15.51 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 15.23 | 15.25 | 0.02 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,111 | 86,753 | $ 15.33 | $ 1,329,617 | - | 9.01 - 21.30 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:36:16 | 6 | $ 15.235 | USD |
Period:
Draw Mode:
Aerie Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 714.18M | 46.89M | 45.81M | $ 83.14M | $ - | -3.98 | -4.10 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 66.85k | 2.40% |
Aerie Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AERI Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 15.09 | 16.22 | 14.95 | 15.69 | 334,559 | 0.14 | 0.93% |
| 1 Month | 18.84 | 18.90 | 14.92 | 15.80 | 423,869 | -3.61 | -19.16% |
| 3 Months | 16.875 | 19.26 | 14.91 | 16.61 | 511,355 | -1.65 | -9.75% |
| 6 Months | 18.11 | 21.30 | 14.91 | 17.46 | 565,488 | -2.88 | -15.9% |
| 1 Year | 13.12 | 21.30 | 9.01 | 14.53 | 632,947 | 2.11 | 16.08% |
| 3 Years | 71.40 | 71.55 | 9.01 | 23.90 | 753,730 | -56.17 | -78.67% |
| 5 Years | 17.17 | 74.75 | 9.01 | 31.22 | 664,199 | -1.94 | -11.3% |
Aerie Pharmaceuticals Description
| Aerie Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is focused on the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases, and retinal diseases. Its main products are Rhopressa and Roclatan. The company mainly operates in North America. |
